Pivotal Therapeutics Inc.'s ticker is and the CUSIP is 72582E104. A total of 1 filers reported holding Pivotal Therapeutics Inc. in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | -100.0% | 437,166 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $1,000 | – | 437,166 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 437,166 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 437,166 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 437,166 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $4,000 | 0.0% | 437,166 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | -69.2% | 437,166 | 0.0% | 0.00% | -70.0% |
| Q4 2015 | $13,000 | -53.6% | 437,166 | -37.6% | 0.01% | -50.0% |
| Q3 2015 | $28,000 | -39.1% | 700,569 | -28.5% | 0.02% | -31.0% |
| Q2 2015 | $46,000 | -29.2% | 979,791 | -9.3% | 0.03% | -23.7% |
| Q1 2015 | $65,000 | +4.8% | 1,079,791 | +5.2% | 0.04% | +11.8% |
| Q4 2014 | $62,000 | -39.8% | 1,026,889 | 0.0% | 0.03% | -34.6% |
| Q3 2014 | $103,000 | +27.2% | 1,026,889 | +2.7% | 0.05% | +30.0% |
| Q2 2014 | $81,000 | -51.2% | 1,000,000 | +2.7% | 0.04% | -55.6% |
| Q1 2014 | $166,000 | – | 974,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GOLDMAN CAPITAL MANAGEMENT INC | 979,791 | $46,000 | 0.03% |